NE Field Diagnostics Ltd. of Eyal at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine

NE Field Diagnostics Ltd.

P.O. Box 29, 4410001 Eyal
Kibutz Eyal, 45840 Eyal
Israel
Telephone +972 54 3063091
Fax +972 9 7662529
info@nefield.com

This company is co-exhibitor of
Israel Export & International Cooperation Institute

Hall map

MEDICA 2018 hall map (Hall 16): stand G40

Fairground map

MEDICA 2018 fairground map: Hall 16

Our range of products

Product categories

  • 01  Electromedical Equipment / Medical Technology
  • 01.06  Intense medicine / anesthesiology / respiration
  • 01.06.03  Patient monitoring systems

Patient monitoring systems

Our products

Product category: Patient monitoring systems

THE FUTURE OF LUNG FUNCTION TESTING

Tidal Breathing
Our test is done during tidal breathing, also known as quiet breathing. Without the need to blow forcefully, making it ideal for people with respiratory symptoms and small children.

No Cooperation
Our lung function test does not require any special instructions or breathing maneuvers. The test is completely automated and can be performed on all ages, including neonates.

Airway Resistance (Raw)
We measure Airway-Resistance, the most physically accurate parameter for measuring airway obstructions and twice as sensitive as FEV1 (forced expiratory volume in 1 sec).

Non Invasive
NE Field’s testing method is non invasive and only requires breathing through our device through a disposable mouthpiece.

More Less

About us

Company details

NE-Field Diagnostics Ltd. was established in 2015 to develop and commercialize an innovative technology for pulmonary function testing and monitoring. Our device enables an effortless lung function test that can be carried out with virtually no patient collaboration and without any need for testing proficiency or training. By this we establish our aim of producing a home-care device that can test babies, infants, children, disabled and in-bed patients while significantly increasing test reliability.

Today’s most common test (Spirometry), involves forced breathing maneuvers and inferior metrics – The amount of air expelled in 1 second (FEV1). Our technology is able to detect the alveolar pressure (the driving pressure of breathing) and by that calculate Airway-Resistance, known to be three times more effective than FEV1 at determining an obstructed airway. An obstructed airway is the main symptom of most respiratory diseases such as COPD and Asthma.

During our 3 minute test, in addition to measuring Airway-Resistance, we also provide data regarding respiratory compliance and work-of-breathing, supplying triple the data when compared to Spirometry. NE-Field has demonstrated its technology by invasive in-vivo testing with an Alpha prototype, proving its ability to deduce airway resistance, lung compliance and work-of-breathing successfully. We have also begun human trials in Hadassah Medical Center in Jerusalem.

More Less